Estimating risk
-
Upload
tarek-tawfik-amin -
Category
Health & Medicine
-
view
349 -
download
1
description
Transcript of Estimating risk
04/10/2023 Dr. Tarek Tawfik 1
Estimating Risk
Dr. Tarek Tawfik Amin
Public Health Department, Cairo [email protected]
Objectives
• By the end of this session, attendees should be able to:
1- Differentiate between probability, Odd, and risk with it variants.
2- Recall the basics for calculating Odds and relative risk and interpret the results.
3- Define the indications of applying the risk parameters.
Definitions of terms: Probability, risk and Odd
• Probability: Is the proportion (%) of times an event would occur if an observation was repeated many times.
• Risk: Is the probability of an event among those experiencing the event divided by the number who could experience it (at risk).
• Odds: Probability of an event divided by the probability of the event not happening.
Probability Odds (chance) Risk
Proportion (%)0-1 (100%)
Ratio Probability/(1-probaility) 0 to infinity
Ratio (rate)0 to infinity
The 10 year probability of OP hip fracture among those aged 70 years is 0.23 (23%).
The Odds for OP hip fracture is 0.23/(1.0.23)=0.30
Incidence of OP hip fracture among those aged 70 years.
No denominator Denominator
Attack rate is an other example
Risk
04/10/2023 Dr. Tarek Tawfik 6
A-Absolute Risk
The incidence of a disease in a population is termed absolute risk.
* Can indicate the magnitude of risk in a group of people with a certain exposure, but:
* It does not take into consideration the risk of disease in the non-exposed individuals,
* It does not indicate whether the exposure is associated with an increased risk of disease.
Absolute risk doe not stipulate an explicit comparison.
Rubella in 1st trimester: what is the risk that my child will be malformed? Abortion will be decided on the basis of this information.
04/10/2023 Dr. Tarek Tawfik 7
B-Relative risk: Determination that a certain disease is associated with a certain exposure.
By using the (case-control) and cohort studies we can assess whether there is an excess risk of disease in persons who have been exposed.
Comparing different risks among different groups to assess the presence of excessive risk (the incidence rate ‘attack rates’ and the difference in the risks).
Estimation of relative risks are vital in determining who will be at a higher risk following the exposure.
Relative Risk (concept)
o Case-control and cohort studies are designed to determine whether there is an association between exposure to a factor and development of a disease.
If an association exists, how strong is it?
o In cohort study: what is the ratio of the risk of disease in exposed individuals to the risk of disease in non-exposed individuals? (RR=relative risk).
Relative risk (RR) =
Risk in exposed (incidence in the exposed)
Risk in non-exposed (incidence in the non-exposed)
Basic Structure of cohort study
Disease-free
Dis
eased
Disease-free
Unexposedto factor
Exposed to factor
Population
Develop Disease (a)
Disease-free(b)
Develop Disease (c)
Disease-free(d)
Sam
ple
Starting point
Present time Future timeFollow
Com
parin
g th
e in
cid
en
ce o
f dis
ease in
each
gro
up
The Relative Risk is calculated for exposure
Disease-free
Dis
eased
Population
Diseased (cases)
Disease-free(controls)
Exposed to factor(a)
Unexposed to factor(b)
Unexposed to factor(d)
Exposed to factor(c)
Sam
ple
Trace Present time
Starting pointPast time
Basic structure of case-control design
The O
dds “ch
ance
of e
xposu
re
Is calcu
late
d b
etw
een b
oth
gro
ups
The following table depicts the outcomes of isoniazid/placebo trial among children with HIV (death within 6 months).
Total Alive Dead (within 6 months)
Interventions
131 110 21 Placebo
132 121 11 Isoniazid
What is the risk of dying?
Risk=21/131=0.160
Risk=11/132=0.083
Absolute risk difference (ARD)=risk in placebo-risk in isoniazid= 0.077
Net relative risk (NRR)=risk in placebo/risk in isoniazid= 1.928
Relative risk reduction (RRR)=risk in placebo-risk in isoniazid/risk in placebo= 0.48
Number needed to treat (NNT)=1/ARD=1/0.077=13
Relative risk (RR)
Total No breast cancer
Breast cancer Mammography
100 b-90 a-10 Positive
100,100 d-998980 c-20 Negative
In Cohort design
RR= a/(a+b)÷c/(c+d)10/(100) ÷20(100,100)=0.1/0.0002= 500
The relative risk (RR)
Total No lung cancer
Lung cancer
600 582 18 Smokers
1200 1194 6 Non
Cohort
stu
dy
Risk for smokers=18/600=0.03Risk for non-smokers=6/1200=0.005RR=0.03/0.005=6
Interpreting the Relative Risk(measure the strength of the association)
Risk in exposed equal to risk in non-exposed (no association).Risk in exposed greater than risk in non-exposed (positive association; possibly causal).Risk in exposed less than risk in non-exposed (negative association; possibly protective).
If RR = 1
If RR > 1
If RR < 1
Calculating the Relative Risk in Cohort Studies
Then follow to see whether
Incidence rate of disease
Totals Disease does not develop
Disease develops
a a+b
c c+d
a+b
c+d
b
d
a
c
First select
a c
a+b c+d
Exposed
No exposed
=incidence in exposed =incidence in non-exposed
Hypothetical Cohort3,000 smokers and 5,000 non-smokers to investigate the relation of smoking to the development of coronary heart disease (CHD)
over a 1-year period.
Incidence per 1,000/year
Totals Do not develop CHD
Develop CHD
28.0
17.4
3,000
5,000
2,916
4,913
84
87
Smoke cigarettes
Do not smoke
cigarettes
Incidence among the exposed=84/3,000 = 28.0 per 1,000
Incidence among the non-exposed =87/5000= 17.4 per 1,000
Relative risk= Incidence in exposed
Incidence in non-exposed=
28.0/17.4 = 1.61
04/10/2023 Dr. Tarek Tawfik 17
Example: the British Heart Study
A large cohort study of 7735 men aged 40-59 years randomly selected from general practices in 24 British towns, with the aim of identifying risk factors for ischemic heart disease. At recruitment to the study, the men were asked about a number of demographic and lifestyle, including information on cigarette smoking habits.Of the 7718 men who provided information on smoking status, 5899 (76.4 %) had smoked at some stage during their lives (including those who were current smokers and those who were ex-smokers).Over subsequent 10 years, 650 of these 7718 men (8.4 %) had a myocardial infarction (MI).
MI in subsequent 10 years
Smoking status at baseline
Total No Yes
5899
1819
7718
5336 (90.5%)
1732 (95.2%)
7068(71.6%)
563 (9.5%)
87 (4.8%)
650 (8.4%)
Ever smoked
Never smoked
Total
The estimated relative risk=(563/5899)(87/1819)
=2.00CI = 1.60-2.49
(does not include 1)
The middle aged man who has eversmoke is twice as likely to suffer a
MI over the next 10 years period as a man who has never smoked.
Odds ratio
The Odds ratio (relative odds)
* In order to calculate a relative risk, we must have values for the incidence in the exposed and non-exposed, as can be obtained in the cohort study.
* In a case-control study, however, we do not know the incidence in the exposed population or the incidence in the non-exposed population because we start with diseased people (cases) and non-diseased people (controls).
* Hence, we can not estimate the RR in case-control study directly and we implement another measure of association called Odds ratio.
04/10/2023 Dr. Tarek Tawfik 21
Defining the Odds ratio in Cohort and Case-control studies.
Suppose we betting on a horse named Little Beauty, which has a 60% probability of wining the race (P). Little Beauty, therefore has a 40 % probability of losing (1-P). What are the odds that the horse will win the race?
The odds is defined as: the ratio of the number of ways the event can occur to the number of ways the event can not occur.
Odds =
Odds = P/(1-P) or 60 %/40 % = 1.5:1 = 1.5Probability of wining is 60 %, while the odds
(chance) of wining is 1.5 times.
Probability that Little Beauty will win the race
Probability that Little Beauty will lose the race
Odds ratio (OR)
o An odds ratio (OR) is a measure of association between an exposure and an outcome.
o The OR represents the odds that an outcome will occur given a particular exposure, compared to the odds of the outcome occurring in the absence of that exposure.
o Odds ratios are most commonly used in case-control studies, however they can also be used in cross-sectional and cohort study designs as well (with some modifications and/or assumptions).
OR
• Rare disease assumption (prevalence < 10%).
• Case control-design • Regression analysis • Meta-analysis
Calculation
Total None Diseased Case control study
a+b Exposed+ not diseased (b)
Cases+ exposed (a)
Exposed
c+d Not exposed+ not diseased
(d)
Cases-not exposed (c)
Non-exposed
Odds ratio= a/c÷b/d= ad/bc
Prevalence among the diseased/prevalence among the non-diseased
OR=1 Exposure does not affect odds of outcomeOR>1 Exposure associated with higher odds of outcomeOR<1 Exposure associated with lower odds of outcome
Odds ratio
Total No lung cancer
Lung cancer Case control study
110 b-30 a-80 Smoking
90 d-70 c-20 None
80x70=560030x20=6005600/600=9.3
Or 80/20÷30/70=9.3
The Odds ratio (OR)
Total No lung cancer
Lung cancer
110 30 80 Smokers
90 70 20 Non
Case
contr
ol st
udy
Odds for smokers=80/30=2.67Odds for non-smokers=20/70=0.29OR=80*70/30*20=9.33
Odds Ratios in Case-Control and Cohort Studies
Do not develop disease
Develop
disease
Cohort
b a Exposed
d c Not exposed
Controls Cases Case-control
b a History of exposure
d c No history of exposure
Odds ratio= Odds that an exposed person
Develops diseaseOdds that a non-exposed Person develops disease
=a/b c/d
=ad bc
Odds ratio= Odds that a case was exposed
Odds that a control was exposed =a/c b/d
=ad bc
Example: HRT
* A total of 1327 women aged 50 to 81 years with hip fractures, who lived in a largely urban area in Sweden, were investigated in this un-matched case-controls study. They were compared with 3262 controls within the same age range selected from the National register.
* Interest was centered on determining whether postmenopausal hormone replacement therapy (HRT) substantially reduced the risk of hip fracture.
* The results in the table show the number of women who were current users of HRT and those who had never used or formerly used HRT in cases and controls.
Total
Never used HRT/ former user of
HRT
Current users of HRT
1327
3262
4589
1287 (30%)
3023
4310
40 (14%)
239
279
With hip fracture (cases)
Without hip fracture (controls)
Total
The observed Odds ratio= (40X3023)(239X1287)
=0.39C.I = 0.28 to 0.56
A postmenopausal woman in this age range in Sweden who was a current user of HRT thus had 39 % of the
risk of hip fracture of a woman who had never used
or formerly used HRTBeing current user of HRT
reduced the risk of hip fracture by 61%.
When is the Odds Ratio a Good Estimate of the Relative Risk?
In case-control, only the odds ratio can be calculated as a measure of association, whereas in a cohort, either the relative risk or the odds ratio is a valid measure of association.
Nevertheless, estimate of RR can be used in interpreting case-control study in the following occasions:When the cases are representative, with regard to history of exposure, of all people with disease in the population from which the cases are drawn.When the controls are representative with regard to history of exposure, of all people without the disease in the population from which the cases were drawn.When the disease being studied dose not occur frequently.
Odds Ratios and Relative risk
Total Do not develo
p disease
Disease develop
s
10,000
10,000
9800
9900
200
100
Exposed
Not exposed
Total Do not develop disease
Develop disease
100
100
50
75
50
25
Exposed
Not exposed
Relative risk =200/10,000
100/10,000= 2Odds Ratio=200X9900100X9800=
2.02
Relative Risk= 50/10025/100
=2Odds ratio= 50X7525X50
=3Odds ratio inflated due to high prevalence of the outcome (>10%)
In cohort, the discrepancy between RR and OddsIs less (the denominator is always large)
04/10/2023 Dr. Tarek Tawfik 33
Remember
The relative odds (odds ratio) is a useful measure of association in both case-control and prospective studies “Cohort”.
In a cohort study, the relative risk can be calculated directly.
In a case-control study, the relative risk cannot be calculated directly, so that the relative odds or odds ratio (cross-product ratio) is used as an estimate of the relative risk when the risk of the disease is low.
04/10/2023 Dr. Tarek Tawfik 34
Calculating the Odds ratio in a Matched Pairs Case-Control Study.
According to the type of exposure, case-control study can be classified into four groups:
- pairs in which both cases and controls were exposed.
Concordant pairs - pairs in which neither the cases nor the controls were exposed.
- pairs in which the case was exposed but the control was not.
Discordant pairs - pairs in which the control was exposed and the case was not.
2X2 tableControl
Cases Not exposed Exposed
b The case was exposed and the
control was not
a Both the case and control
were exposed
Exposed
dNeither the case nor the control
was exposed
cThe case was not exposed
and the control was exposed
Not exposed
Calculation entail the discordant pairs only (b and c), we ignore the concordant pairs, because they do not contribute to our knowledge of how cases and controls differ in regard to past history of exposure.
The odds ratio will then equals = b /c
04/10/2023 Dr. Tarek Tawfik 36
Case-control study of brain tumors in children.
o A number of studies have suggested that children with higher birth weights are at increased risk for childhood cancer.
o In the next analysis, exposure is defined as birth weight greater than 8 lbs.
Total Normal control
Cases < 8lbs 8+ lbs
26 18 8 8+ lbs
45 38 7 < 8 lbs
71 56 15 Total
Odds ratio= 18/7 = 2.57
2= 4.00P = 0.046
04/10/2023 Dr. Tarek Tawfik 37
Attributable Risk
How much of the disease that occurs can be attributed to a certain exposure?Attributable risk is defined as the amount or proportion of disease incidence (or disease risk) that can be attributed to a specific exposure.How much of lung cancer risk experienced by smokers can be attributed to smoking?More important than RR as it addresses important clinical practice and public health. How much of the risk (incidence) of disease can we hope to prevent if we are able to eliminate exposure to the agent in question?
04/10/2023 Dr. Tarek Tawfik 38
Attributable Risk for the Exposed Group
Exposed Group
In nonExposed
group
Leve
l of risk
Background risk
In the non-exposed group
In exposed group
Incidence due to exposure
Incidence not dueto exposure
04/10/2023 Dr. Tarek Tawfik 40
Calculations
The incidence of a disease that is attributable to the exposure in the exposed group can be calculated as follow:
(incidence in the exposed group) - (incidence in the non-exposed group)
Then, what proportion of the risk in exposed persons is due to the exposure?
(incidence in the exposed group) - (incidence in the non-exposed group)
incidence in the exposed group
04/10/2023 Dr. Tarek Tawfik 41
Attributable Risk for the Total Population
What proportion of the disease incidence in a total population (both exposed and non-exposed) can be attributable to a specific exposure?
What would be the total impact of a prevention program on the community?
Calculations entail:(Incidence in the total population) – (incidence in non-exposed
group ‘background risk’).
In proportion:(Incidence in the total population) – (incidence in non-exposed group
‘background risk’). Incidence in total population
Example for calculating the attributable risk in the exposed group
Incidence per 1,000 per year
Total Do not develop CHD
Develop CHD
Smoking status
28.0
17.4
3,000
5,000
2,916
4,913
84
87
Smoke cigarettes
Do not smoke cigarettes
Incidence among smokers = 84/3,000 = 28.0 per 1,000Incidence among non smokers = 87/5,000 = 17.4 per 1,000
The AR = (incidence in exposed group) – (incidence in the non exposed group) =
28.0 – 17.4 /1,000 = 10.6 /1,000????In proportion = The AR = (incidence in exposed group) –
(incidence in the non exposed group) /( incidence in exposed group)
= 28.0 – 17.6/ 28.0 = 10.6/28.0 = 0.379 = 37.9 %?????
04/10/2023 Dr. Tarek Tawfik 43
What does this mean?
The attributable risk = 10.6 /1,000, it means that 10.6 of the 28.0/1,000 incident cases in smokers are attributable to the fact that these people smoke.
Thus if we had an effective smoking cessation campaign, we could prevent 10.6 of the 28/1,000 incident cases of CHD that smokers experience.
In proportion, 37.9 % of the morbidity from CHD among smokers may be attributable to smoking and could presumably be prevented by eliminating smoking.
04/10/2023 Dr. Tarek Tawfik 44
Attributable risk in total population
The incidence in the total population can be calculated by subtracting the background risk.
(incidence in the total population) – (incidence in the non-
exposed group), for calculation we must know the incidence of the disease in the total population (which we often do not know), or all of the following three values, from which we can then calculate the incidence in the total population:
The incidence among exposed. The incidence among the non-exposed. The proportion of the total population that
exposed (frequently assumed or judged).
04/10/2023 Dr. Tarek Tawfik 45
AR in total population.
Assuming that the incidence in the total population of smoking is 44% (and therefore the proportion of non-smokers is 56%).
The incidence in the total population can then be calculated as follows:
(incidence in smokers)(% of smokers in the population) + (incidence in non-smokers)(% of non-smokers in population).
= (28.0/1,000)(0.44)+(17.4/1,000)(0.56)= 22.1/1,000 Then the AR= 22.1/1,000 – 17.4/1,000 = 4.7/1,000. It means that, if we an effective prevention
program, how much reduction in the incidence of the CHD could be anticipated.
04/10/2023 Dr. Tarek Tawfik 46
AR in total population
* Proportion of incidence in the total population =
(incidence in the total population) – (incidence in the non-exposed group)/ incidence in the total population = 22.1-17.4/22.1= 21.3%.
* Thus, 21.3 % of the incidence of CHD in this total population can be attributed to smoking, and if an effective prevention program eliminated smoking, the best we could hope to achieve would be a reduction of 21.3 % in the incidence of CHD in the total population which consisting of both smoking and non-smoking.
Thank you